Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Noncash or Part Noncash Acquisition, Fixed Assets Acquired

1.7 / 5 stars · 18/54 Roast Me

Citius Pharmaceuticals, Inc. Noncash or Part Noncash Acquisition, Fixed Assets Acquired

Citius Pharmaceuticals, Inc. (CTXR) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $1.37 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-23.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2025-12-23

  • Citius Pharmaceuticals, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2025 was $1.37M, a 77.69% decline from fiscal 2024.
  • Citius Pharmaceuticals, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $6.13M.
Period endNoncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month
2025-09-30$1.37M
10-K · filed 2025-12-23
2024-09-30$6.13M
10-K · filed 2025-12-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36